Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Q4 2025 Annual earnings

Reported February 12, 2026 · After market close

Revenue$693.2MBeat by $5.2MDiluted EPS$2.51Miss by $0.18
Revenue estimate$688.0M
EPS estimate$2.69

Next report

Jul 30, 2026 (in a month)
Revenue estimate$624.8M
EPS estimate$1.78

Financials

Q4 2025

Income statement

See full
Revenue$693.2M+3.9%
Gross profit$345.2M+0.9%
Net income$720.0M+201%
EPS (diluted)$26.39+203%

Balance sheet

See full
Cash & equivalents$532.2M+8.7%
Total debt$1.4B+0.7%
Total equity$7.5B+13.5%
Total assets$10.6B+12.9%

Cash flow

See full
Operating cash flow$164.9M+32.8%
CapEx$45.8M+6.8%
Free cash flow$119.1M+46.5%

Valuation & ratios

Q4 2025

Valuation

See full
Market cap$8.17B-11.1%
Enterprise value$9.03B-10.5%
P/E10.8×—
P/S3.2×-0.4×

Profitability

See full
Gross margin51.9%-1.9pp
Net margin29.4%+17.2pp
FCF margin14.5%+3.2pp

Returns & leverage

See full
Return on equity10.8%+6.4pp
Debt / equity0.2×0.0×
Current ratio5.6×-0.9×

Segments

By segment

See full
Clinical Diagnostics$425.3M+8.4%
Life Science$267.9M-2.6%
All Other Segments--100%

By geography

See full
Europe$242.6M+9.4%
Asia Pacific$161.8M+10.5%
Americas$44.7M+8.2%

Versus estimates

Revenue

Q1 2026$592.1MBeat by $784.1K
Q4 2025$693.2MBeat by $5.2M
Q3 2025$653.0MBeat by $1.5MQ2 2025$651.6MMiss by $55.0MQ1 2025$585.4MBeat by $12.2MQ4 2024$667.5MMiss by $12.3M

Diluted EPS

Q1 2026$1.89Miss by $0.12
Q4 2025$2.51Miss by $0.18
Q3 2025-$12.70Miss by $14.59Q2 2025$11.67Beat by $9.92Q1 2025$2.29Beat by $0.47Q4 2024-$25.57Miss by $28.43

Ask the moment Bio-Rad Laboratories, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Rad Laboratories, Inc. report Q4 2025 earnings?
Bio-Rad Laboratories, Inc. (BIO.B) reported Q4 2025 earnings on February 12, 2026 after market close.
What were Bio-Rad Laboratories, Inc.'s Q4 2025 revenue and EPS?
Bio-Rad Laboratories, Inc. reported revenue of $693.2M and diluted EPS of $2.51 for Q4 2025.
Did Bio-Rad Laboratories, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $688.0M by $5.2M. EPS missed the consensus estimate of $2.69 by $0.18.
How did Bio-Rad Laboratories, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.9% from $667.5M a year earlier.
Where can I find Bio-Rad Laboratories, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0000012208-26-000007) and the 10-K periodic report (0000012208-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.